Renal Medicine, Wide Bay Hospital and Health Service, Bundaberg, Queensland, Australia
Rural Clinical School, Faculty of Medicine, The University of Queensland, Bundaberg, Queensland, Australia.
BMJ Open. 2022 Feb 22;12(2):e052790. doi: 10.1136/bmjopen-2021-052790.
Chronic kidney disease (CKD) is a rapidly increasing and global phenomenon which carries high morbidity and mortality. Although timely referral from primary care to secondary care confers favourable outcomes, it is not possible for every patient with CKD to be managed at secondary care. With 1 in 10 Australians currently living with markers of CKD against a workforce of about 600 nephrology specialists, a risk stratification strategy is required that will reliably identify individuals whose kidney disease is likely to progress.
This study will undertake a retrospective secondary analysis of the Chronic Kidney Disease Queensland Registry (CKD.QLD) data of consented adults to examine the referral patterns to specialist nephrology services from primary care providers and map the patient trajectory and outcomes to inform the optimal referral timing for disease mitigation. Patient data over a 5-year period will be examined to determine the impact of the kidney failure risk equation-based risk stratification on the referral patterns, disease progression and patient outcomes. The results will inform considerations of a risk stratification strategy that will ensure adequate predialysis management and add to the discussion of the time interval between referral and initiation of kidney replacement therapy or development of cardiovascular events.
This protocol was approved by the Ethics Committee of the Royal Brisbane and Women's Hospital in January 2021 (LNR/2020/QRBW/69707 14/01/2021). The HREC waived the requirement for patient consent as all patients had consented for the use of their data for the purpose of research on recruitment into CKD.QLD Registry. The results will be presented as a component of a PhD study with The University of Queensland. It is anticipated that the results will be presented at health-related conferences (local, national and possibly international) and via publication in peer-reviewed academic journals.
慢性肾脏病(CKD)是一种迅速增加且具有全球性的现象,其发病率和死亡率都很高。尽管及时从初级保健转诊到二级保健可带来有利的结果,但并非每个 CKD 患者都能在二级保健机构得到管理。目前,澳大利亚每 10 人中就有 1 人患有 CKD,而肾脏病专家的劳动力约为 600 人,因此需要一种风险分层策略,以便可靠地识别出那些肾脏疾病可能进展的个体。
本研究将对同意参与的慢性肾脏病昆士兰州登记处(CKD.QLD)数据进行回顾性二次分析,以检查初级保健提供者向专科肾脏病服务转诊的模式,并绘制患者轨迹和结局,为减轻疾病提供最佳转诊时机。将检查 5 年期间的患者数据,以确定基于肾衰竭风险方程的风险分层对转诊模式、疾病进展和患者结局的影响。研究结果将为考虑一种风险分层策略提供信息,该策略将确保充分的透析前管理,并为转诊和开始肾脏替代治疗或心血管事件发展之间的时间间隔的讨论增添内容。
本方案于 2021 年 1 月获得皇家布里斯班妇女医院伦理委员会的批准(LNR/2020/QRBW/69707 14/01/2021)。HREC 豁免了患者同意的要求,因为所有患者都同意将其数据用于 CKD.QLD 登记处的研究招募目的。研究结果将作为昆士兰大学博士研究的一部分呈现。预计结果将在相关健康会议(本地、国家和可能国际)上展示,并通过在同行评议的学术期刊上发表来展示。